ChemImage Selected to Develop Final Prototypes to Support the U.S. Army Next Generation Chemical Detector Program
ChemImage announced that the US Army has exercised the second option under its Next Generation Chemical Detector (NGCD) contract. Under the Option, ChemImage will design, fabricate and test Final Prototype sensors designed to detect and locate chemical warfare agents (CWA) on environmental surfaces. This work will be done under the direction of the Joint Project Manager for Nuclear, Biological, and Chemical Contamination Avoidance (JPM-NBC-CA).
Under the Option, ChemImage will continue the refinement of its portable hyperspectral imaging technology for CWA detection and produce Final Prototypes that will be evaluated by the Government for both operational utility and CWA detection performance. "The award of this Option enables ChemImage to build on the work performed in the Breadboard and Brassboard phases of the Program and get one step closer to fielding reliable and novel surface contamination detection sensors," stated ChemImage Project Manager, Charles W. Gardner, Ph.D., PMP.
"Proliferation of CWA continues to be a problem in our world," stated Marie Molnar Hammond, Vice President of Marketing and Business Director. "We are pleased to continue our interaction with the U. S. Army to provide handheld instruments that dramatically lessen the warfighter impact of these terrible weapons of mass destruction."
About ChemImage Corporation
ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.
ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics.
For more information, contact ChemImage.